These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16358631)

  • 21. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 22. Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries.
    Ferrari P;
    J Hum Hypertens; 2009 Mar; 23(3):151-9. PubMed ID: 18784735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public health value of fixed-dose combinations in hypertension.
    Ruilope LM; Burnier M; Muszbek N; Brown RE; Keskinaslan A; Ferber P; Harms G
    Blood Press Suppl; 2008 Jun; 1():5-14. PubMed ID: 18705530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 25. Observational study of hypertension in Matelica, Italy (Matelica hypertension study).
    Sossai P; Amenta F; Porcellati C
    Clin Exp Hypertens; 2007 Nov; 29(8):531-7. PubMed ID: 18058478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.
    Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B;
    Heart; 2008 Feb; 94(2):e4. PubMed ID: 17916665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The health economics of hypertension.
    Smith DG
    Manag Care; 2004 Jul; 13(7 Suppl):17-22; discussion 23-6. PubMed ID: 15352769
    [No Abstract]   [Full Text] [Related]  

  • 28. [New guidelines put their faith in European standards. Not rigid instruction but guiding principle].
    Aumiller J
    MMW Fortschr Med; 2006 Feb; 148(7):41, 43-4. PubMed ID: 16529362
    [No Abstract]   [Full Text] [Related]  

  • 29. First-line drugs for hypertension.
    Spence JD
    CMAJ; 2001 Jan; 164(2):176-8. PubMed ID: 11332306
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B; Angman A; Hjemdahl P
    Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypertension, a health economics perspective.
    Alcocer L; Cueto L
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):147-55. PubMed ID: 19124418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Investigation and treatment of primary hypertension].
    Lindstedt I; Nilsson PM
    Lakartidningen; 2008 Jul 23-Aug 5; 105(30-31):2107-12. PubMed ID: 18751450
    [No Abstract]   [Full Text] [Related]  

  • 33. The economics of hypertension control: some basic issues.
    Maynard A
    J Hum Hypertens; 1992 Dec; 6(6):417-20. PubMed ID: 1296004
    [No Abstract]   [Full Text] [Related]  

  • 34. Symposium reporter 2003. New therapeutic options in the management of hypertension to heart failure. Orlando, Florida, USA, March 6, 2003.
    Cohn JN; Velazquez EJ; Musher J
    J Am Med Dir Assoc; 2003; ():1-16, quiz 17. PubMed ID: 12924409
    [No Abstract]   [Full Text] [Related]  

  • 35. The economic impact of the introduction of home blood pressure measurement for the diagnosis and treatment of hypertension.
    Funahashi J; Ohkubo T; Fukunaga H; Kikuya M; Takada N; Asayama K; Metoki H; Obara T; Inoue R; Hashimoto J; Totsune K; Kobayashi M; Imai Y
    Blood Press Monit; 2006 Oct; 11(5):257-67. PubMed ID: 16932035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Quality control of medical care of hypertension].
    Vetter W; Lüscher T
    Schweiz Rundsch Med Prax; 1983 Jun; 72(26):885-8. PubMed ID: 6889280
    [No Abstract]   [Full Text] [Related]  

  • 37. Health insurance status and hypertension monitoring and control in the United States.
    Duru OK; Vargas RB; Kermah D; Pan D; Norris KC
    Am J Hypertens; 2007 Apr; 20(4):348-53. PubMed ID: 17386339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [No value for money with certain antihypertensive agents].
    Edling A; Löfmark R; Vinge E; Carlsson P; André M; Melltorp G; Edhag O; Dahlqvist R; Andersson I; Magnusson D
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3565. PubMed ID: 19133587
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta-blockers and the treatment of hypertension.
    Williams B
    J Hypertens; 2007 Jul; 25(7):1351-3. PubMed ID: 17563554
    [No Abstract]   [Full Text] [Related]  

  • 40. [Arterial hypertension and cardiac pathology. Diagnostic and therapeutic guidelines presented by the Joint Commission of the ANMCO-SIC-SIIA. Assoziane Nazionale Medici Cardiologi Ospedalieri. Società Italiana di Cardiologia. Società Italiana dell'Ipertensione Arteriosa].
    Agabiti-Rosei E; Giovannini E; Mancia G; Novo S; Pede S; Rappelli A; Sau F; Trevi G; Verdecchia P
    G Ital Cardiol; 1999 Mar; 29(3):341-56. PubMed ID: 10231683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.